| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0073 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |